SNDL Inc.
General ticker "SNDL" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $465.5M (TTM average)
SNDL Inc. follows the US Stock Market performance with the rate: 47.1%.
Estimated limits based on current volatility of 1.7%: low 1.71$, high 1.78$
Factors to consider:
- Total employees count: 1064 as of 2019
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.25$, 2.59$]
- 2025-12-31 to 2026-12-31 estimated range: [1.15$, 2.42$]
Financial Metrics affecting the SNDL estimates:
- Positive: with PPE of -6.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 2.62 > -0.66
- Positive: Interest expense per share per price, % of 1.14 <= 3.41
- Negative: negative Industry operating cash flow (median)
- Positive: 6.82 < Operating cash flow per share per price, % of 8.10
- Positive: Inventory ratio change, % of -0.17 <= 0
- Positive: Shareholder equity ratio, % of 84.00 > 63.39
Short-term SNDL quotes
Long-term SNDL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | CA$909.01MM | CA$920.45MM |
| Operating Expenses | CA$1,072.18MM | CA$1,024.26MM |
| Operating Income | CA$-163.17MM | CA$-103.81MM |
| Non-Operating Income | CA$-8.85MM | CA$-1.80MM |
| Interest Expense | CA$7.92MM | CA$7.70MM |
| R&D Expense | CA$0.32MM | CA$0.35MM |
| Income(Loss) | CA$-172.02MM | CA$-105.61MM |
| Taxes | CA$0.00MM | CA$-9.40MM |
| Profit(Loss)* | CA$-172.02MM | CA$-94.80MM |
| Stockholders Equity | CA$1,212.07MM | CA$1,133.36MM |
| Inventory | CA$129.49MM | CA$129.11MM |
| Assets | CA$1,473.16MM | CA$1,349.24MM |
| Operating Cash Flow | CA$-16.65MM | CA$54.91MM |
| Capital expenditure | CA$7.93MM | CA$11.02MM |
| Investing Cash Flow | CA$-24.82MM | CA$17.76MM |
| Financing Cash Flow | CA$-43.08MM | CA$-49.36MM |
| Earnings Per Share** | CA$-0.66 | CA$-0.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.